Chase Sun(300026.SZ)

Last Updated 00:00:00
longbridge loading

Chase Sun Pharmaceuticals released its performance for the first three quarters, with a net profit attributable to the parent company of 80.7629 million yuan, a decrease of 52.03%

Zhitong·
SZ
300026
-1.50%
Zhitong·
SZ
300026
-1.50%

Chase Sun Pharmaceuticals released its performance for the first half of the year, with a net profit attributable to the parent company of 78.63 million yuan, a decrease of 46.95%

Zhitong·
SZ
300026
-1.50%
Zhitong·
SZ
300026
-1.50%

The traditional Chinese medicine concept continues to strengthen, with Layn hitting the daily limit, and companies such as Zhongsheng Pharmaceutical, Kanion Pharmaceutical, JINGXIN, Zhendong Pharmacy, CONBA, and Chase Sun also rising

Zhitong·
SH
600572
-1.64%
SZ
300026
-1.50%
SZ
002166
+1.13%
Zhitong·
SH
600572
-1.64%
SZ
300026
-1.50%
SZ
002166
+1.13%

Chase Sun Pharmaceuticals released its first-quarter performance, with a net profit attributable to the parent company of 60.3297 million yuan, an increase of 3.80%

Zhitong·
SZ
300026
-1.50%
Zhitong·
SZ
300026
-1.50%

Hubei Chenmei Traditional Chinese Medicine signed agreements with multiple parties to jointly promote the high-quality development of the entire industrial chain of Dabieshan authentic medicinal materials

Zhitong·
SZ
300026
-1.50%
Zhitong·
SZ
300026
-1.50%

Chase Sun: Delay in the disclosure of the 2024 annual report

Zhitong·
SZ
300026
-1.50%
Zhitong·
SZ
300026
-1.50%

Chase Sun Pharmaceutical's injectable Labetalol hydrochloride has obtained the drug clinical trial approval

Zhitong·
SZ
300026
-1.50%
Zhitong·
SZ
300026
-1.50%

Chase Sun's net profit for the year 2024 is 51.052 million yuan, a year-on-year decrease of 89.92%

Zhitong·
SZ
300026
-1.50%
Zhitong·
SZ
300026
-1.50%

Chase Sun Pharmaceuticals issued a profit warning, expecting a net profit of 48 million to 62 million yuan for the fiscal year 2024, a year-on-year decrease of 90.53% to 87.76%

Zhitong·
SZ
300026
-1.50%
Zhitong·
SZ
300026
-1.50%

Chase Sun's shareholder Yao Xiaoqing plans to reduce holdings by no more than 2.56% of shares

Zhitong·
SZ
300026
-1.50%
Zhitong·
SZ
300026
-1.50%
© 2026 Longbridge｜Disclaimer